Brief: CanSino Biologics Reports Widened Net Loss For Q1
28/04/2026 09:45
April 28 (Reuters) - CanSino Biologics Inc 688185.SS: Q1 NET LOSS AT 40.4 MILLION YUAN ($5.91 million) Source text Further company coverage: 688185.SS ($1 = 6.8355 Chinese yuan renminbi) (Reporting by Beijing Newsroom) ((yukun.zhang@thomsonreuters.com;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025